Novel motif:70: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif70_MAATCGC
|novel_motifs_human_sample_pval=11376-118A8_11051;0.99915,11327-117E4_11969;0.937265,11473-119C6_11054;0.673376,11474-119C7_12067;0.29074...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:53, 9 September 2013
name: | motif70_MAATCGC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090304 | nucleic acid metabolic process | 4.035764e-13 |
GO:0046755 | non-lytic virus budding | 9.082867e-12 |
GO:0006302 | double-strand break repair | 2.892207e-11 |
GO:0006313 | transposition, DNA-mediated | 3.249451e-10 |
GO:0006103 | 2-oxoglutarate metabolic process | 1.002081e-9 |
GO:0016070 | RNA metabolic process | 1.016977e-8 |
GO:0031503 | protein complex localization | 1.128223e-8 |
GO:0010467 | gene expression | 1.905840e-8 |
GO:0033566 | gamma-tubulin complex localization | 4.414252e-8 |
GO:0032774 | RNA biosynthetic process | 5.775564e-8 |
GO:0034629 | cellular protein complex localization | 7.816715e-8 |
GO:0006139 | nucleobase-containing compound metabolic process | 7.966447e-8 |
GO:0051321 | meiotic cell cycle | 1.352623e-7 |
GO:0048291 | isotype switching to IgG isotypes | 2.239522e-7 |
GO:0009436 | glyoxylate catabolic process | 2.239522e-7 |
GO:0002368 | B cell cytokine production | 2.239522e-7 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 2.239522e-7 |
GO:0006457 | protein folding | 2.795545e-7 |
GO:0044260 | cellular macromolecule metabolic process | 2.866908e-7 |
GO:0070669 | response to interleukin-2 | 3.043525e-7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.073457e-7 |
GO:0006807 | nitrogen compound metabolic process | 3.341484e-7 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 3.385754e-7 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 3.438300e-7 |
GO:0006351 | transcription, DNA-dependent | 3.706294e-7 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 4.412405e-7 |
GO:0060839 | endothelial cell fate commitment | 5.868278e-7 |
GO:0019067 | viral assembly, maturation, egress, and release | 6.039635e-7 |
GO:2000162 | negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | 9.021501e-7 |
GO:2000168 | negative regulation of planar cell polarity pathway involved in neural tube closure | 9.021501e-7 |
GO:2000166 | negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | 9.021501e-7 |
GO:2000164 | negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | 9.021501e-7 |
GO:2000151 | negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 9.021501e-7 |
GO:2000055 | positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 9.021501e-7 |
GO:0061310 | canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | 9.021501e-7 |
GO:2000149 | negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | 9.021501e-7 |
GO:0006657 | CDP-choline pathway | 1.019237e-6 |
GO:0016579 | protein deubiquitination | 1.170502e-6 |
GO:0090245 | axis elongation involved in somitogenesis | 1.328838e-6 |
GO:0021874 | Wnt receptor signaling pathway involved in forebrain neuroblast division | 1.328838e-6 |
GO:0070536 | protein K63-linked deubiquitination | 1.336632e-6 |
GO:0002711 | positive regulation of T cell mediated immunity | 1.388583e-6 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 1.640488e-6 |
GO:0044332 | Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.887674e-6 |
GO:0044335 | canonical Wnt receptor signaling pathway involved in neural crest cell differentiation | 1.907162e-6 |
GO:0009785 | blue light signaling pathway | 1.950494e-6 |
GO:0000723 | telomere maintenance | 1.965626e-6 |
GO:0007126 | meiosis | 2.428475e-6 |
GO:0051320 | S phase | 2.429148e-6 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 2.520625e-6 |
GO:0070535 | histone H2A K63-linked ubiquitination | 2.950650e-6 |
GO:0014020 | primary neural tube formation | 3.323265e-6 |
GO:0010172 | embryonic body morphogenesis | 3.704317e-6 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 3.799450e-6 |
GO:0021570 | rhombomere 4 development | 4.260223e-6 |
GO:0008334 | histone mRNA metabolic process | 4.271910e-6 |
GO:0001843 | neural tube closure | 4.323005e-6 |
GO:0060836 | lymphatic endothelial cell differentiation | 4.356564e-6 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 4.356564e-6 |
GO:0060606 | tube closure | 5.389138e-6 |
GO:0051289 | protein homotetramerization | 6.179725e-6 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 6.417934e-6 |
GO:0072148 | epithelial cell fate commitment | 6.609773e-6 |
GO:0006529 | asparagine biosynthetic process | 7.199349e-6 |
GO:0006259 | DNA metabolic process | 8.010935e-6 |
GO:0032200 | telomere organization | 8.161613e-6 |
GO:0000236 | mitotic prometaphase | 8.863400e-6 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 1.055374e-5 |
GO:0002011 | morphogenesis of an epithelial sheet | 1.056384e-5 |
GO:0060691 | epithelial cell maturation involved in salivary gland development | 1.060984e-5 |
GO:0070086 | ubiquitin-dependent endocytosis | 1.060984e-5 |
GO:0060096 | serotonin secretion, neurotransmission | 1.060984e-5 |
GO:0060236 | regulation of mitotic spindle organization | 1.109651e-5 |
GO:0009637 | response to blue light | 1.109651e-5 |
GO:0045008 | depyrimidination | 1.124603e-5 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 1.236372e-5 |
GO:0006310 | DNA recombination | 1.295822e-5 |
GO:0071639 | positive regulation of monocyte chemotactic protein-1 production | 1.405397e-5 |
GO:0046544 | development of secondary male sexual characteristics | 1.507806e-5 |
GO:0071044 | histone mRNA catabolic process | 1.789540e-5 |
GO:2000351 | regulation of endothelial cell apoptosis | 1.792078e-5 |
GO:0070646 | protein modification by small protein removal | 2.055229e-5 |
GO:0043170 | macromolecule metabolic process | 2.392863e-5 |
GO:0006919 | activation of caspase activity | 2.475676e-5 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 2.486371e-5 |
GO:0014029 | neural crest formation | 2.685441e-5 |
GO:0071637 | regulation of monocyte chemotactic protein-1 production | 2.918222e-5 |
GO:0032663 | regulation of interleukin-2 production | 2.948315e-5 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 3.371801e-5 |
GO:0060980 | cell migration involved in coronary vasculogenesis | 3.418976e-5 |
GO:0046674 | induction of retinal programmed cell death | 3.719662e-5 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 3.719662e-5 |
GO:0032976 | release of matrix enzymes from mitochondria | 3.719662e-5 |
GO:0002352 | B cell negative selection | 3.719662e-5 |
GO:0001777 | T cell homeostatic proliferation | 3.719662e-5 |
GO:0006101 | citrate metabolic process | 3.818717e-5 |
GO:0002339 | B cell selection | 3.828224e-5 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 4.163530e-5 |
GO:0021612 | facial nerve structural organization | 4.313522e-5 |
GO:0051594 | detection of glucose | 4.549787e-5 |
GO:0003281 | ventricular septum development | 4.961920e-5 |
GO:0007091 | mitotic metaphase/anaphase transition | 5.463881e-5 |
GO:0021510 | spinal cord development | 5.469388e-5 |
GO:0071887 | leukocyte apoptosis | 5.787052e-5 |
GO:0090394 | negative regulation of excitatory postsynaptic membrane potential | 5.849247e-5 |
GO:0006281 | DNA repair | 6.037342e-5 |
GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 6.130124e-5 |
GO:0060379 | cardiac muscle cell myoblast differentiation | 6.467396e-5 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 6.486231e-5 |
GO:0042026 | protein refolding | 6.699838e-5 |
GO:0044237 | cellular metabolic process | 7.174048e-5 |
GO:0033127 | regulation of histone phosphorylation | 8.053025e-5 |
GO:0000279 | M phase | 8.129894e-5 |
GO:0003279 | cardiac septum development | 8.540265e-5 |
GO:0009886 | post-embryonic morphogenesis | 8.554066e-5 |
GO:0006235 | dTTP biosynthetic process | 8.626338e-5 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 9.032757e-5 |
GO:0072229 | metanephric proximal convoluted tubule development | 9.151941e-5 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 9.151941e-5 |
GO:0046449 | creatinine metabolic process | 9.501579e-5 |
GO:0021915 | neural tube development | 9.596589e-5 |
GO:0007144 | female meiosis I | 1.006305e-4 |
GO:0035176 | social behavior | 1.133883e-4 |
GO:2000124 | regulation of endocannabinoid signaling pathway | 1.169045e-4 |
GO:0006102 | isocitrate metabolic process | 1.169045e-4 |
GO:0006552 | leucine catabolic process | 1.179597e-4 |
GO:0000726 | non-recombinational repair | 1.279028e-4 |
GO:0090129 | positive regulation of synapse maturation | 1.311508e-4 |
GO:0035065 | regulation of histone acetylation | 1.315921e-4 |
GO:0021794 | thalamus development | 1.420102e-4 |
GO:0070164 | negative regulation of adiponectin secretion | 1.516771e-4 |
GO:0035505 | positive regulation of myosin light chain kinase activity | 1.516771e-4 |
GO:0060355 | positive regulation of cell adhesion molecule production | 1.516771e-4 |
GO:0006244 | pyrimidine nucleotide catabolic process | 1.574140e-4 |
GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 1.581556e-4 |
GO:0001783 | B cell apoptosis | 1.596819e-4 |
GO:0021546 | rhombomere development | 1.618971e-4 |
GO:0021569 | rhombomere 3 development | 1.732395e-4 |
GO:0019530 | taurine metabolic process | 1.732395e-4 |
GO:0010833 | telomere maintenance via telomere lengthening | 1.770635e-4 |
GO:0015936 | coenzyme A metabolic process | 1.774239e-4 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 1.800137e-4 |
GO:0021512 | spinal cord anterior/posterior patterning | 1.801443e-4 |
GO:0021532 | neural tube patterning | 1.843378e-4 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 1.903493e-4 |
GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 1.972272e-4 |
GO:0046676 | negative regulation of insulin secretion | 1.980364e-4 |
GO:0006479 | protein methylation | 1.993486e-4 |
GO:0032367 | intracellular cholesterol transport | 2.019417e-4 |
GO:0090128 | regulation of synapse maturation | 2.025250e-4 |
GO:0001522 | pseudouridine synthesis | 2.025250e-4 |
GO:0006285 | base-excision repair, AP site formation | 2.088220e-4 |
GO:0070163 | regulation of adiponectin secretion | 2.088258e-4 |
GO:0003218 | cardiac left ventricle formation | 2.122776e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.132323e-4 |
GO:0090291 | negative regulation of osteoclast proliferation | 2.137329e-4 |
GO:2000349 | negative regulation of CD40 signaling pathway | 2.137329e-4 |
GO:0072573 | tolerance induction to lipopolysaccharide | 2.137329e-4 |
GO:2000347 | positive regulation of hepatocyte proliferation | 2.137329e-4 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 2.137329e-4 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 2.137329e-4 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.137329e-4 |
GO:0045931 | positive regulation of mitotic cell cycle | 2.188438e-4 |
GO:2000352 | negative regulation of endothelial cell apoptosis | 2.213178e-4 |
GO:0000084 | S phase of mitotic cell cycle | 2.250859e-4 |
GO:0034333 | adherens junction assembly | 2.390815e-4 |
GO:0035441 | cell migration involved in vasculogenesis | 2.432381e-4 |
GO:0010107 | potassium ion import | 2.432381e-4 |
GO:0090399 | replicative senescence | 2.489588e-4 |
GO:0009956 | radial pattern formation | 2.501856e-4 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 2.526854e-4 |
GO:0071542 | dopaminergic neuron differentiation | 2.526854e-4 |
GO:0043280 | positive regulation of caspase activity | 2.678394e-4 |
GO:0006790 | sulfur compound metabolic process | 2.691081e-4 |
GO:0061381 | cell migration in diencephalon | 2.761931e-4 |
GO:0061379 | inferior colliculus development | 2.761931e-4 |
GO:0061374 | mammillothalamic axonal tract development | 2.761931e-4 |
GO:0021855 | hypothalamus cell migration | 2.761931e-4 |
GO:0097105 | presynaptic membrane assembly | 2.831236e-4 |
GO:0006549 | isoleucine metabolic process | 2.980204e-4 |
GO:0030035 | microspike assembly | 2.989768e-4 |
GO:0042418 | epinephrine biosynthetic process | 3.102725e-4 |
GO:0006585 | dopamine biosynthetic process from tyrosine | 3.102725e-4 |
GO:0090278 | negative regulation of peptide hormone secretion | 3.165559e-4 |
GO:0070227 | lymphocyte apoptosis | 3.186630e-4 |
GO:0000255 | allantoin metabolic process | 3.245940e-4 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 3.283306e-4 |
GO:0007412 | axon target recognition | 3.283306e-4 |
GO:0048103 | somatic stem cell division | 3.359668e-4 |
GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway | 3.488987e-4 |
GO:0046796 | viral genome transport in host cell | 3.578313e-4 |
GO:0003057 | regulation of the force of heart contraction by chemical signal | 3.604283e-4 |
GO:0031115 | negative regulation of microtubule polymerization | 3.787827e-4 |
GO:0050996 | positive regulation of lipid catabolic process | 3.837873e-4 |
GO:0046847 | filopodium assembly | 3.850941e-4 |
GO:0072195 | kidney smooth muscle cell differentiation | 3.866792e-4 |
GO:0072105 | ureteric peristalsis | 3.866792e-4 |
GO:0021997 | neural plate axis specification | 3.866792e-4 |
GO:0070858 | negative regulation of bile acid biosynthetic process | 3.866792e-4 |
GO:0003108 | negative regulation of the force of heart contraction by chemical signal | 4.041763e-4 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 4.181299e-4 |
GO:0046888 | negative regulation of hormone secretion | 4.201739e-4 |
GO:0043648 | dicarboxylic acid metabolic process | 4.250079e-4 |
GO:0001660 | fever generation | 4.289340e-4 |
GO:0009081 | branched chain family amino acid metabolic process | 4.318587e-4 |
GO:0031397 | negative regulation of protein ubiquitination | 4.397268e-4 |
GO:0071951 | conversion of methionyl-tRNA to N-formyl-methionyl-tRNA | 4.470573e-4 |
GO:0021610 | facial nerve morphogenesis | 4.509074e-4 |
GO:0000414 | regulation of histone H3-K36 methylation | 4.509074e-4 |
GO:0046778 | modification by virus of host mRNA processing | 4.530338e-4 |
GO:0032365 | intracellular lipid transport | 4.609957e-4 |
GO:0032729 | positive regulation of interferon-gamma production | 4.705191e-4 |
GO:0042149 | cellular response to glucose starvation | 4.744299e-4 |
GO:0090224 | regulation of spindle organization | 4.880180e-4 |
GO:0030917 | midbrain-hindbrain boundary development | 4.986596e-4 |
GO:0051262 | protein tetramerization | 5.116124e-4 |
GO:2000348 | regulation of CD40 signaling pathway | 5.239217e-4 |
GO:0035066 | positive regulation of histone acetylation | 5.547686e-4 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 5.776824e-4 |
GO:0060558 | regulation of calcidiol 1-monooxygenase activity | 5.989868e-4 |
GO:0009059 | macromolecule biosynthetic process | 6.016674e-4 |
GO:0000724 | double-strand break repair via homologous recombination | 6.084048e-4 |
GO:0060690 | epithelial cell differentiation involved in salivary gland development | 6.110386e-4 |
GO:0071625 | vocalization behavior | 6.118367e-4 |
GO:0048541 | Peyer's patch development | 6.265740e-4 |
GO:0022403 | cell cycle phase | 6.359266e-4 |
GO:0061324 | canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation | 6.381677e-4 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 6.381677e-4 |
GO:0001985 | negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure | 6.459587e-4 |
GO:0021873 | forebrain neuroblast division | 6.507084e-4 |
GO:0007127 | meiosis I | 6.541949e-4 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 6.619996e-4 |
GO:0021561 | facial nerve development | 6.619996e-4 |
GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 6.669561e-4 |
GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 6.669561e-4 |
GO:0030497 | fatty acid elongation | 6.962946e-4 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 6.977451e-4 |
GO:0000725 | recombinational repair | 6.977451e-4 |
GO:0031427 | response to methotrexate | 7.039697e-4 |
GO:0045769 | negative regulation of asymmetric cell division | 7.213511e-4 |
GO:0042414 | epinephrine metabolic process | 7.213511e-4 |
GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway | 7.326670e-4 |
GO:0006695 | cholesterol biosynthetic process | 7.358973e-4 |
GO:0043137 | DNA replication, removal of RNA primer | 7.375561e-4 |
GO:0003360 | brainstem development | 7.375561e-4 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 7.606239e-4 |
GO:0002238 | response to molecule of fungal origin | 7.660309e-4 |
GO:0021943 | formation of radial glial scaffolds | 7.660309e-4 |
GO:0042770 | signal transduction in response to DNA damage | 7.829201e-4 |
GO:2000050 | regulation of non-canonical Wnt receptor signaling pathway | 7.900252e-4 |
GO:0021604 | cranial nerve structural organization | 7.974857e-4 |
GO:0006338 | chromatin remodeling | 8.122104e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 8.304895e-4 |
GO:0042113 | B cell activation | 8.423462e-4 |
GO:0071108 | protein K48-linked deubiquitination | 8.473323e-4 |
GO:0006551 | leucine metabolic process | 8.737008e-4 |
GO:0060968 | regulation of gene silencing | 8.836344e-4 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 9.496419e-4 |
GO:0008156 | negative regulation of DNA replication | 9.598066e-4 |
GO:0060292 | long term synaptic depression | 9.630883e-4 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 9.914392e-4 |
GO:0071157 | negative regulation of cell cycle arrest | 1.008310e-3 |
GO:0006284 | base-excision repair | 1.010852e-3 |
GO:0090149 | membrane fission involved in mitochondrial fission | 1.014276e-3 |
GO:0003374 | dynamin polymerization involved in mitochondrial fission | 1.014276e-3 |
GO:0009088 | threonine biosynthetic process | 1.014276e-3 |
GO:0045830 | positive regulation of isotype switching | 1.042146e-3 |
GO:0034063 | stress granule assembly | 1.052140e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.072846e-3 |
GO:0002792 | negative regulation of peptide secretion | 1.075879e-3 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 1.076692e-3 |
GO:0045076 | regulation of interleukin-2 biosynthetic process | 1.082959e-3 |
GO:0051402 | neuron apoptosis | 1.092309e-3 |
GO:0034135 | regulation of toll-like receptor 2 signaling pathway | 1.099166e-3 |
GO:0060173 | limb development | 1.119584e-3 |
GO:0070544 | histone H3-K36 demethylation | 1.125026e-3 |
GO:0002706 | regulation of lymphocyte mediated immunity | 1.125230e-3 |
GO:0001841 | neural tube formation | 1.146483e-3 |
GO:0006573 | valine metabolic process | 1.159068e-3 |
GO:0048537 | mucosal-associated lymphoid tissue development | 1.176037e-3 |
GO:0007213 | muscarinic acetylcholine receptor signaling pathway | 1.176127e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.194226e-3 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 1.212836e-3 |
GO:0048469 | cell maturation | 1.215924e-3 |
GO:0071397 | cellular response to cholesterol | 1.222396e-3 |
GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation | 1.244325e-3 |
GO:0010564 | regulation of cell cycle process | 1.265238e-3 |
GO:0016571 | histone methylation | 1.270277e-3 |
GO:0032770 | positive regulation of monooxygenase activity | 1.284490e-3 |
GO:0006982 | response to lipid hydroperoxide | 1.320907e-3 |
GO:0002158 | osteoclast proliferation | 1.334863e-3 |
GO:0046487 | glyoxylate metabolic process | 1.353317e-3 |
GO:0042214 | terpene metabolic process | 1.372695e-3 |
GO:0014813 | satellite cell commitment | 1.372695e-3 |
GO:0000038 | very long-chain fatty acid metabolic process | 1.380123e-3 |
GO:0044340 | canonical Wnt receptor signaling pathway involved in regulation of cell proliferation | 1.408570e-3 |
GO:0035137 | hindlimb morphogenesis | 1.453755e-3 |
GO:0001922 | B-1 B cell homeostasis | 1.479564e-3 |
GO:0032464 | positive regulation of protein homooligomerization | 1.483801e-3 |
GO:0014805 | smooth muscle adaptation | 1.541836e-3 |
GO:0008152 | metabolic process | 1.556862e-3 |
GO:0006974 | response to DNA damage stimulus | 1.609464e-3 |
GO:0071156 | regulation of cell cycle arrest | 1.616090e-3 |
GO:0051276 | chromosome organization | 1.625501e-3 |
GO:2000345 | regulation of hepatocyte proliferation | 1.672863e-3 |
GO:0002709 | regulation of T cell mediated immunity | 1.677112e-3 |
GO:0070857 | regulation of bile acid biosynthetic process | 1.677938e-3 |
GO:0090244 | Wnt receptor signaling pathway involved in somitogenesis | 1.681113e-3 |
GO:0035261 | external genitalia morphogenesis | 1.681113e-3 |
GO:0033129 | positive regulation of histone phosphorylation | 1.695500e-3 |
GO:0008630 | DNA damage response, signal transduction resulting in induction of apoptosis | 1.720286e-3 |
GO:0050796 | regulation of insulin secretion | 1.757013e-3 |
GO:0009067 | aspartate family amino acid biosynthetic process | 1.765179e-3 |
GO:0035425 | autocrine signaling | 1.770409e-3 |
GO:0032229 | negative regulation of synaptic transmission, GABAergic | 1.771308e-3 |
GO:0097090 | presynaptic membrane organization | 1.772473e-3 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.787441e-3 |
GO:0043254 | regulation of protein complex assembly | 1.794362e-3 |
GO:0052314 | phytoalexin metabolic process | 1.801505e-3 |
GO:0033342 | negative regulation of collagen binding | 1.801505e-3 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 1.801505e-3 |
GO:0060977 | coronary vasculature morphogenesis | 1.831521e-3 |
GO:0048285 | organelle fission | 1.837130e-3 |
GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity | 1.849856e-3 |
GO:0046619 | optic placode formation involved in camera-type eye formation | 1.871817e-3 |
GO:0051252 | regulation of RNA metabolic process | 1.939023e-3 |
GO:0002639 | positive regulation of immunoglobulin production | 1.995820e-3 |
GO:0060019 | radial glial cell differentiation | 2.004979e-3 |
GO:0007131 | reciprocal meiotic recombination | 2.006087e-3 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 2.011452e-3 |
GO:0006825 | copper ion transport | 2.015462e-3 |
GO:0051726 | regulation of cell cycle | 2.048330e-3 |
GO:0046358 | butyrate biosynthetic process | 2.057489e-3 |
GO:2000114 | regulation of establishment of cell polarity | 2.075103e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 2.079056e-3 |
GO:0002331 | pre-B cell allelic exclusion | 2.081577e-3 |
GO:0007128 | meiotic prophase I | 2.102669e-3 |
GO:0046850 | regulation of bone remodeling | 2.110735e-3 |
GO:0043414 | macromolecule methylation | 2.144860e-3 |
GO:0040032 | post-embryonic body morphogenesis | 2.162660e-3 |
GO:0000239 | pachytene | 2.162660e-3 |
GO:0006749 | glutathione metabolic process | 2.207896e-3 |
GO:0045911 | positive regulation of DNA recombination | 2.233971e-3 |
GO:0021932 | hindbrain radial glia guided cell migration | 2.284393e-3 |
GO:0007032 | endosome organization | 2.302181e-3 |
GO:0046690 | response to tellurium ion | 2.305204e-3 |
GO:0035444 | nickel ion transmembrane transport | 2.305204e-3 |
GO:0070627 | ferrous iron import | 2.305204e-3 |
GO:0071352 | cellular response to interleukin-2 | 2.305204e-3 |
GO:0015676 | vanadium ion transport | 2.305204e-3 |
GO:0015692 | lead ion transport | 2.305204e-3 |
GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 2.305204e-3 |
GO:0009645 | response to low light intensity stimulus | 2.305204e-3 |
GO:0034755 | iron ion transmembrane transport | 2.307965e-3 |
GO:0015959 | diadenosine polyphosphate metabolic process | 2.307965e-3 |
GO:0031104 | dendrite regeneration | 2.375159e-3 |
GO:0060039 | pericardium development | 2.391845e-3 |
GO:0006308 | DNA catabolic process | 2.394482e-3 |
GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity | 2.551732e-3 |
GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway | 2.551732e-3 |
GO:0019915 | lipid storage | 2.553677e-3 |
GO:0051301 | cell division | 2.555643e-3 |
GO:0030730 | sequestering of triglyceride | 2.585824e-3 |
GO:0080164 | regulation of nitric oxide metabolic process | 2.607351e-3 |
GO:0043381 | negative regulation of memory T cell differentiation | 2.607351e-3 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 2.645879e-3 |
GO:0050691 | regulation of defense response to virus by host | 2.645879e-3 |
GO:0021987 | cerebral cortex development | 2.663549e-3 |
GO:0032819 | positive regulation of natural killer cell proliferation | 2.705581e-3 |
GO:0001983 | baroreceptor response to increased systemic arterial blood pressure | 2.705581e-3 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 2.724987e-3 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 2.724987e-3 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 2.724987e-3 |
GO:0010587 | miRNA catabolic process | 2.724987e-3 |
GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 2.724987e-3 |
GO:0021986 | habenula development | 2.741460e-3 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 2.751158e-3 |
GO:0006105 | succinate metabolic process | 2.802557e-3 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 2.813629e-3 |
GO:0032768 | regulation of monooxygenase activity | 2.837828e-3 |
GO:0032825 | positive regulation of natural killer cell differentiation | 2.858669e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 2.886463e-3 |
GO:0009822 | alkaloid catabolic process | 2.887906e-3 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 2.887906e-3 |
GO:0051661 | maintenance of centrosome location | 2.887906e-3 |
GO:0045472 | response to ether | 2.887906e-3 |
GO:0019218 | regulation of steroid metabolic process | 2.925136e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 2.942157e-3 |
GO:0090273 | regulation of somatostatin secretion | 3.018421e-3 |
GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure | 3.018421e-3 |
GO:0051204 | protein insertion into mitochondrial membrane | 3.052736e-3 |
GO:0031055 | chromatin remodeling at centromere | 3.056016e-3 |
GO:0022038 | corpus callosum development | 3.086390e-3 |
GO:0072194 | kidney smooth muscle tissue development | 3.094410e-3 |
GO:0050893 | sensory processing | 3.094410e-3 |
GO:0006426 | glycyl-tRNA aminoacylation | 3.108515e-3 |
GO:0006273 | lagging strand elongation | 3.108515e-3 |
GO:0010459 | negative regulation of heart rate | 3.122486e-3 |
GO:0045588 | positive regulation of gamma-delta T cell differentiation | 3.185030e-3 |
GO:0033865 | nucleoside bisphosphate metabolic process | 3.188243e-3 |
GO:0034103 | regulation of tissue remodeling | 3.190674e-3 |
GO:0032201 | telomere maintenance via semi-conservative replication | 3.199164e-3 |
GO:0032000 | positive regulation of fatty acid beta-oxidation | 3.264618e-3 |
GO:0051205 | protein insertion into membrane | 3.357219e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 3.372019e-3 |
GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 3.394826e-3 |
GO:0060689 | cell differentiation involved in salivary gland development | 3.394826e-3 |
GO:0045410 | positive regulation of interleukin-6 biosynthetic process | 3.408850e-3 |
GO:0072560 | type B pancreatic cell maturation | 3.429051e-3 |
GO:0070295 | renal water absorption | 3.429051e-3 |
GO:0030910 | olfactory placode formation | 3.429051e-3 |
GO:0032645 | regulation of granulocyte macrophage colony-stimulating factor production | 3.488059e-3 |
GO:0014048 | regulation of glutamate secretion | 3.510248e-3 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 3.517889e-3 |
GO:0001838 | embryonic epithelial tube formation | 3.520434e-3 |
GO:0060061 | Spemann organizer formation | 3.527260e-3 |
GO:0033076 | isoquinoline alkaloid metabolic process | 3.553358e-3 |
GO:0006325 | chromatin organization | 3.684319e-3 |
GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification | 3.684455e-3 |
GO:0015891 | siderophore transport | 3.715629e-3 |
GO:0042339 | keratan sulfate metabolic process | 3.715629e-3 |
GO:0006463 | steroid hormone receptor complex assembly | 3.715629e-3 |
GO:0035246 | peptidyl-arginine N-methylation | 3.727964e-3 |
GO:0032817 | regulation of natural killer cell proliferation | 3.727964e-3 |
GO:0045822 | negative regulation of heart contraction | 3.841926e-3 |
GO:0006927 | transformed cell apoptosis | 3.890100e-3 |
GO:0055024 | regulation of cardiac muscle tissue development | 3.890634e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 3.923976e-3 |
GO:0060973 | cell migration involved in heart development | 3.953696e-3 |
GO:0006600 | creatine metabolic process | 4.175992e-3 |
GO:0048593 | camera-type eye morphogenesis | 4.228508e-3 |
GO:0008535 | respiratory chain complex IV assembly | 4.237216e-3 |
GO:0031424 | keratinization | 4.282531e-3 |
GO:2000270 | negative regulation of fibroblast apoptosis | 4.304962e-3 |
GO:2000271 | positive regulation of fibroblast apoptosis | 4.304962e-3 |
GO:2000080 | negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 4.304962e-3 |
GO:0071773 | cellular response to BMP stimulus | 4.304962e-3 |
GO:0044345 | stromal-epithelial cell signaling involved in prostate gland development | 4.304962e-3 |
GO:0017145 | stem cell division | 4.335620e-3 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 4.364463e-3 |
GO:0043044 | ATP-dependent chromatin remodeling | 4.364463e-3 |
GO:0051790 | short-chain fatty acid biosynthetic process | 4.476285e-3 |
GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway | 4.476285e-3 |
GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation | 4.476285e-3 |
GO:0032066 | nucleolus to nucleoplasm transport | 4.476285e-3 |
GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient | 4.476285e-3 |
GO:0006533 | aspartate catabolic process | 4.476285e-3 |
GO:0000018 | regulation of DNA recombination | 4.497689e-3 |
GO:0060535 | trachea cartilage morphogenesis | 4.535459e-3 |
GO:0018216 | peptidyl-arginine methylation | 4.559945e-3 |
GO:0046851 | negative regulation of bone remodeling | 4.633782e-3 |
GO:0031396 | regulation of protein ubiquitination | 4.649189e-3 |
GO:0043486 | histone exchange | 4.756443e-3 |
GO:0051324 | prophase | 4.761681e-3 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 4.788598e-3 |
GO:0006528 | asparagine metabolic process | 4.807838e-3 |
GO:0006334 | nucleosome assembly | 4.827721e-3 |
GO:0070672 | response to interleukin-15 | 4.848868e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 5.009422e-3 |
GO:0046645 | positive regulation of gamma-delta T cell activation | 5.025930e-3 |
GO:0008299 | isoprenoid biosynthetic process | 5.068569e-3 |
GO:0035148 | tube formation | 5.119134e-3 |
GO:0072175 | epithelial tube formation | 5.126164e-3 |
GO:2000079 | regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 5.145786e-3 |
GO:0051097 | negative regulation of helicase activity | 5.145786e-3 |
GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 5.167818e-3 |
GO:0046185 | aldehyde catabolic process | 5.217644e-3 |
GO:0032259 | methylation | 5.239051e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 5.246462e-3 |
GO:0060976 | coronary vasculature development | 5.289211e-3 |
GO:0035634 | response to stilbenoid | 5.289211e-3 |
GO:0000266 | mitochondrial fission | 5.289211e-3 |
GO:0022616 | DNA strand elongation | 5.298073e-3 |
GO:0021700 | developmental maturation | 5.300888e-3 |
GO:0001782 | B cell homeostasis | 5.391958e-3 |
GO:0006607 | NLS-bearing substrate import into nucleus | 5.410055e-3 |
GO:0042416 | dopamine biosynthetic process | 5.422615e-3 |
GO:0034392 | negative regulation of smooth muscle cell apoptosis | 5.458560e-3 |
GO:0009068 | aspartate family amino acid catabolic process | 5.485203e-3 |
GO:0051569 | regulation of histone H3-K4 methylation | 5.485203e-3 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 5.554638e-3 |
GO:0001743 | optic placode formation | 5.651540e-3 |
GO:0014050 | negative regulation of glutamate secretion | 5.694294e-3 |
GO:0050891 | multicellular organismal water homeostasis | 5.703402e-3 |
GO:0001659 | temperature homeostasis | 5.743359e-3 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.754486e-3 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 5.760175e-3 |
GO:0032876 | negative regulation of DNA endoreduplication | 5.760175e-3 |
GO:0010952 | positive regulation of peptidase activity | 5.852090e-3 |
GO:0061316 | canonical Wnt receptor signaling pathway involved in heart development | 5.884541e-3 |
GO:0051353 | positive regulation of oxidoreductase activity | 5.938254e-3 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 5.975443e-3 |
GO:0090276 | regulation of peptide hormone secretion | 6.027211e-3 |
GO:0016140 | O-glycoside metabolic process | 6.078583e-3 |
GO:0035024 | negative regulation of Rho protein signal transduction | 6.109727e-3 |
GO:0000019 | regulation of mitotic recombination | 6.110247e-3 |
GO:0071168 | protein localization to chromatin | 6.110247e-3 |
GO:0010948 | negative regulation of cell cycle process | 6.147205e-3 |
GO:0051930 | regulation of sensory perception of pain | 6.194275e-3 |
GO:0001779 | natural killer cell differentiation | 6.292686e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090304 | nucleic acid metabolic process | 1.994331e-16 |
GO:0016070 | RNA metabolic process | 2.861030e-12 |
GO:0006139 | nucleobase-containing compound metabolic process | 7.413870e-12 |
GO:0044260 | cellular macromolecule metabolic process | 1.533992e-11 |
GO:0042733 | embryonic digit morphogenesis | 1.627549e-11 |
GO:0010467 | gene expression | 1.023694e-10 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.504483e-10 |
GO:0006807 | nitrogen compound metabolic process | 8.893119e-10 |
GO:0003309 | type B pancreatic cell differentiation | 9.441651e-10 |
GO:0060429 | epithelium development | 9.780988e-10 |
GO:0001736 | establishment of planar polarity | 1.119363e-9 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 1.316519e-9 |
GO:0001945 | lymph vessel development | 1.536995e-9 |
GO:0007164 | establishment of tissue polarity | 2.716312e-9 |
GO:0051684 | maintenance of Golgi location | 3.641314e-9 |
GO:0046709 | IDP catabolic process | 4.431151e-9 |
GO:0046032 | ADP catabolic process | 4.431151e-9 |
GO:0051726 | regulation of cell cycle | 5.683420e-9 |
GO:0003279 | cardiac septum development | 6.238593e-9 |
GO:0043170 | macromolecule metabolic process | 6.338225e-9 |
GO:0060411 | cardiac septum morphogenesis | 1.093255e-8 |
GO:0051645 | Golgi localization | 2.699758e-8 |
GO:0045786 | negative regulation of cell cycle | 4.790769e-8 |
GO:0030855 | epithelial cell differentiation | 7.301743e-8 |
GO:0006974 | response to DNA damage stimulus | 8.774461e-8 |
GO:0009956 | radial pattern formation | 9.461499e-8 |
GO:0032774 | RNA biosynthetic process | 9.925289e-8 |
GO:0015074 | DNA integration | 1.054522e-7 |
GO:0001738 | morphogenesis of a polarized epithelium | 1.369369e-7 |
GO:0035282 | segmentation | 1.371055e-7 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 1.551173e-7 |
GO:0031577 | spindle checkpoint | 1.640761e-7 |
GO:0051301 | cell division | 2.636669e-7 |
GO:0006351 | transcription, DNA-dependent | 2.686968e-7 |
GO:0007067 | mitosis | 2.914650e-7 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 2.969826e-7 |
GO:0007389 | pattern specification process | 3.556897e-7 |
GO:0009952 | anterior/posterior pattern specification | 3.599216e-7 |
GO:0031503 | protein complex localization | 3.777013e-7 |
GO:0060839 | endothelial cell fate commitment | 3.937405e-7 |
GO:0051661 | maintenance of centrosome location | 4.282727e-7 |
GO:0060836 | lymphatic endothelial cell differentiation | 4.518201e-7 |
GO:0000087 | M phase of mitotic cell cycle | 4.696605e-7 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 5.910800e-7 |
GO:0045165 | cell fate commitment | 5.955319e-7 |
GO:0071156 | regulation of cell cycle arrest | 6.266562e-7 |
GO:0045137 | development of primary sexual characteristics | 6.673101e-7 |
GO:0046452 | dihydrofolate metabolic process | 8.732728e-7 |
GO:0072240 | metanephric DCT cell differentiation | 9.468874e-7 |
GO:0072227 | metanephric macula densa development | 9.468874e-7 |
GO:0043066 | negative regulation of apoptosis | 1.147592e-6 |
GO:0031427 | response to methotrexate | 1.240022e-6 |
GO:0043069 | negative regulation of programmed cell death | 1.305778e-6 |
GO:0048286 | lung alveolus development | 1.375355e-6 |
GO:0006281 | DNA repair | 1.416157e-6 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 1.482575e-6 |
GO:0060412 | ventricular septum morphogenesis | 1.603707e-6 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.609321e-6 |
GO:0061180 | mammary gland epithelium development | 1.774581e-6 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.017681e-6 |
GO:0007493 | endodermal cell fate determination | 2.035677e-6 |
GO:0007548 | sex differentiation | 2.047806e-6 |
GO:0048285 | organelle fission | 2.231136e-6 |
GO:0003002 | regionalization | 2.279784e-6 |
GO:0046661 | male sex differentiation | 2.523897e-6 |
GO:0009059 | macromolecule biosynthetic process | 2.679225e-6 |
GO:0034063 | stress granule assembly | 2.853042e-6 |
GO:0003281 | ventricular septum development | 3.020813e-6 |
GO:0045995 | regulation of embryonic development | 3.063880e-6 |
GO:0072233 | metanephric thick ascending limb development | 3.280594e-6 |
GO:0072218 | metanephric ascending thin limb development | 3.280594e-6 |
GO:0060548 | negative regulation of cell death | 3.404785e-6 |
GO:0042475 | odontogenesis of dentine-containing tooth | 3.604803e-6 |
GO:0071542 | dopaminergic neuron differentiation | 3.652544e-6 |
GO:0003151 | outflow tract morphogenesis | 4.207354e-6 |
GO:0060071 | Wnt receptor signaling pathway, planar cell polarity pathway | 4.394822e-6 |
GO:0008406 | gonad development | 4.474877e-6 |
GO:0071173 | spindle assembly checkpoint | 5.590752e-6 |
GO:0000279 | M phase | 5.658895e-6 |
GO:0072202 | cell differentiation involved in metanephros development | 5.855346e-6 |
GO:0032908 | regulation of transforming growth factor beta1 production | 5.855346e-6 |
GO:0009236 | cobalamin biosynthetic process | 5.914190e-6 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 6.387055e-6 |
GO:0072148 | epithelial cell fate commitment | 6.465315e-6 |
GO:0060173 | limb development | 6.780211e-6 |
GO:0046031 | ADP metabolic process | 7.278483e-6 |
GO:0060644 | mammary gland epithelial cell differentiation | 7.289085e-6 |
GO:0021889 | olfactory bulb interneuron differentiation | 8.162105e-6 |
GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 8.846900e-6 |
GO:0034622 | cellular macromolecular complex assembly | 9.095485e-6 |
GO:0034421 | post-translational protein acetylation | 9.207778e-6 |
GO:0007566 | embryo implantation | 9.484220e-6 |
GO:0035050 | embryonic heart tube development | 9.630088e-6 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 1.020374e-5 |
GO:0007420 | brain development | 1.152230e-5 |
GO:0030326 | embryonic limb morphogenesis | 1.161836e-5 |
GO:0035967 | cellular response to topologically incorrect protein | 1.195433e-5 |
GO:0021869 | forebrain ventricular zone progenitor cell division | 1.368730e-5 |
GO:0016073 | snRNA metabolic process | 1.382551e-5 |
GO:0050678 | regulation of epithelial cell proliferation | 1.532934e-5 |
GO:0071158 | positive regulation of cell cycle arrest | 1.615548e-5 |
GO:0000578 | embryonic axis specification | 1.627559e-5 |
GO:0006259 | DNA metabolic process | 1.634823e-5 |
GO:0022403 | cell cycle phase | 1.654395e-5 |
GO:0060371 | regulation of atrial cardiomyocyte membrane depolarization | 1.704086e-5 |
GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis | 1.864742e-5 |
GO:0061381 | cell migration in diencephalon | 2.059990e-5 |
GO:0061379 | inferior colliculus development | 2.059990e-5 |
GO:0010045 | response to nickel ion | 2.059990e-5 |
GO:0021855 | hypothalamus cell migration | 2.059990e-5 |
GO:0061374 | mammillothalamic axonal tract development | 2.059990e-5 |
GO:0006355 | regulation of transcription, DNA-dependent | 2.132386e-5 |
GO:0008625 | induction of apoptosis via death domain receptors | 2.379919e-5 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 2.478191e-5 |
GO:0051382 | kinetochore assembly | 2.495486e-5 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 2.495486e-5 |
GO:0022402 | cell cycle process | 2.540236e-5 |
GO:0050680 | negative regulation of epithelial cell proliferation | 2.543774e-5 |
GO:0060575 | intestinal epithelial cell differentiation | 2.635289e-5 |
GO:0002009 | morphogenesis of an epithelium | 2.686537e-5 |
GO:0003310 | pancreatic A cell differentiation | 2.979496e-5 |
GO:0009889 | regulation of biosynthetic process | 3.039701e-5 |
GO:0051252 | regulation of RNA metabolic process | 3.058783e-5 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 3.101941e-5 |
GO:0007223 | Wnt receptor signaling pathway, calcium modulating pathway | 3.180781e-5 |
GO:0022011 | myelination in peripheral nervous system | 3.180781e-5 |
GO:0034621 | cellular macromolecular complex subunit organization | 3.244006e-5 |
GO:0046092 | deoxycytidine metabolic process | 3.329255e-5 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 3.377188e-5 |
GO:2000065 | negative regulation of cortisol biosynthetic process | 3.377188e-5 |
GO:0072259 | metanephric interstitial cell development | 3.377188e-5 |
GO:0072208 | metanephric smooth muscle tissue development | 3.377188e-5 |
GO:0032348 | negative regulation of aldosterone biosynthetic process | 3.377188e-5 |
GO:0072169 | specification of posterior mesonephric tubule identity | 3.377188e-5 |
GO:0072168 | specification of anterior mesonephric tubule identity | 3.377188e-5 |
GO:0072184 | renal vesicle progenitor cell differentiation | 3.377188e-5 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 3.535994e-5 |
GO:0060931 | sinoatrial node cell development | 4.059727e-5 |
GO:0003167 | atrioventricular bundle cell differentiation | 4.059727e-5 |
GO:0042476 | odontogenesis | 4.168463e-5 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 4.428682e-5 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 4.451088e-5 |
GO:0007049 | cell cycle | 4.479864e-5 |
GO:0071712 | ER-associated misfolded protein catabolic process | 5.630273e-5 |
GO:0030970 | retrograde protein transport, ER to cytosol | 5.630273e-5 |
GO:0048608 | reproductive structure development | 5.649002e-5 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5.857137e-5 |
GO:0071635 | negative regulation of transforming growth factor beta production | 5.915221e-5 |
GO:0090399 | replicative senescence | 6.495716e-5 |
GO:0009134 | nucleoside diphosphate catabolic process | 6.495716e-5 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 7.053621e-5 |
GO:0051383 | kinetochore organization | 7.162774e-5 |
GO:0045446 | endothelial cell differentiation | 7.167759e-5 |
GO:0001756 | somitogenesis | 7.273054e-5 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 7.591432e-5 |
GO:0060638 | mesenchymal-epithelial cell signaling | 7.598545e-5 |
GO:0010556 | regulation of macromolecule biosynthetic process | 7.816859e-5 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 8.031172e-5 |
GO:0007569 | cell aging | 8.095122e-5 |
GO:0035136 | forelimb morphogenesis | 8.359744e-5 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 8.391304e-5 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 8.391304e-5 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 8.391304e-5 |
GO:0061350 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 8.569089e-5 |
GO:0061354 | planar cell polarity pathway involved in pericardium morphogenesis | 8.569089e-5 |
GO:0061349 | planar cell polarity pathway involved in cardiac right atrium morphogenesis | 8.569089e-5 |
GO:0070314 | G1 to G0 transition | 8.569089e-5 |
GO:0060210 | metestrus | 8.569089e-5 |
GO:0061348 | planar cell polarity pathway involved in ventricular septum morphogenesis | 8.569089e-5 |
GO:0006651 | diacylglycerol biosynthetic process | 8.569089e-5 |
GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis | 8.569089e-5 |
GO:0000278 | mitotic cell cycle | 8.826370e-5 |
GO:0035115 | embryonic forelimb morphogenesis | 8.961571e-5 |
GO:0048343 | paraxial mesodermal cell fate commitment | 8.997431e-5 |
GO:0061077 | chaperone-mediated protein folding | 9.115944e-5 |
GO:0060921 | sinoatrial node cell differentiation | 9.116364e-5 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 9.267129e-5 |
GO:0042473 | outer ear morphogenesis | 9.320439e-5 |
GO:2000543 | positive regulation of gastrulation | 9.549174e-5 |
GO:0014044 | Schwann cell development | 9.598481e-5 |
GO:0002065 | columnar/cuboidal epithelial cell differentiation | 1.004685e-4 |
GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin | 1.005007e-4 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1.016843e-4 |
GO:0044249 | cellular biosynthetic process | 1.030187e-4 |
GO:0060982 | coronary artery morphogenesis | 1.031797e-4 |
GO:0021904 | dorsal/ventral neural tube patterning | 1.120958e-4 |
GO:0060932 | His-Purkinje system cell differentiation | 1.164520e-4 |
GO:0060926 | pacemaker cell development | 1.164520e-4 |
GO:0014034 | neural crest cell fate commitment | 1.172735e-4 |
GO:0044237 | cellular metabolic process | 1.186037e-4 |
GO:0061053 | somite development | 1.262741e-4 |
GO:0001895 | retina homeostasis | 1.310775e-4 |
GO:0065004 | protein-DNA complex assembly | 1.315502e-4 |
GO:0007422 | peripheral nervous system development | 1.331682e-4 |
GO:0002070 | epithelial cell maturation | 1.338004e-4 |
GO:0060067 | cervix development | 1.361918e-4 |
GO:0022618 | ribonucleoprotein complex assembly | 1.370970e-4 |
GO:0006975 | DNA damage induced protein phosphorylation | 1.372972e-4 |
GO:0021891 | olfactory bulb interneuron development | 1.403313e-4 |
GO:0003158 | endothelium development | 1.406217e-4 |
GO:0010463 | mesenchymal cell proliferation | 1.427157e-4 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.430734e-4 |
GO:0046884 | follicle-stimulating hormone secretion | 1.471575e-4 |
GO:0032275 | luteinizing hormone secretion | 1.471575e-4 |
GO:0008595 | anterior/posterior axis specification, embryo | 1.480112e-4 |
GO:0006261 | DNA-dependent DNA replication | 1.504375e-4 |
GO:0045343 | regulation of MHC class I biosynthetic process | 1.671128e-4 |
GO:0006396 | RNA processing | 1.715039e-4 |
GO:0031326 | regulation of cellular biosynthetic process | 1.724740e-4 |
GO:0072234 | metanephric nephron tubule development | 1.732580e-4 |
GO:0014037 | Schwann cell differentiation | 1.732580e-4 |
GO:0006457 | protein folding | 1.764629e-4 |
GO:0002741 | positive regulation of cytokine secretion involved in immune response | 1.812417e-4 |
GO:0072170 | metanephric tubule development | 1.824564e-4 |
GO:0090103 | cochlea morphogenesis | 1.835420e-4 |
GO:0007417 | central nervous system development | 1.934505e-4 |
GO:0001711 | endodermal cell fate commitment | 1.952478e-4 |
GO:0009058 | biosynthetic process | 1.981947e-4 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 1.991227e-4 |
GO:0046952 | ketone body catabolic process | 2.021861e-4 |
GO:0003163 | sinoatrial node development | 2.052088e-4 |
GO:0072221 | metanephric distal convoluted tubule development | 2.052088e-4 |
GO:0045986 | negative regulation of smooth muscle contraction | 2.107107e-4 |
GO:0072207 | metanephric epithelium development | 2.126078e-4 |
GO:0003205 | cardiac chamber development | 2.174542e-4 |
GO:0060920 | pacemaker cell differentiation | 2.282150e-4 |
GO:0060743 | epithelial cell maturation involved in prostate gland development | 2.372984e-4 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 2.372984e-4 |
GO:0090009 | primitive streak formation | 2.408095e-4 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.408095e-4 |
GO:0060479 | lung cell differentiation | 2.411975e-4 |
GO:0010468 | regulation of gene expression | 2.495753e-4 |
GO:0001975 | response to amphetamine | 2.501048e-4 |
GO:0071826 | ribonucleoprotein complex subunit organization | 2.502823e-4 |
GO:0016071 | mRNA metabolic process | 2.526023e-4 |
GO:0045668 | negative regulation of osteoblast differentiation | 2.536302e-4 |
GO:0072017 | distal tubule development | 2.571593e-4 |
GO:0031576 | G2/M transition checkpoint | 2.597260e-4 |
GO:0060117 | auditory receptor cell development | 2.633010e-4 |
GO:0010470 | regulation of gastrulation | 2.648459e-4 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 2.651930e-4 |
GO:0030799 | regulation of cyclic nucleotide metabolic process | 2.654800e-4 |
GO:0002011 | morphogenesis of an epithelial sheet | 2.661756e-4 |
GO:0051095 | regulation of helicase activity | 2.700103e-4 |
GO:0032287 | peripheral nervous system myelin maintenance | 2.700103e-4 |
GO:0017148 | negative regulation of translation | 2.784915e-4 |
GO:0003323 | type B pancreatic cell development | 2.804546e-4 |
GO:0042770 | signal transduction in response to DNA damage | 2.824523e-4 |
GO:2000798 | negative regulation of amniotic stem cell differentiation | 2.847505e-4 |
GO:2000706 | negative regulation of dense core granule biogenesis | 2.847505e-4 |
GO:0019047 | provirus integration | 2.847505e-4 |
GO:0046591 | embryonic leg joint morphogenesis | 2.866637e-4 |
GO:0030510 | regulation of BMP signaling pathway | 2.949183e-4 |
GO:0035987 | endodermal cell differentiation | 2.974067e-4 |
GO:0048850 | hypophysis morphogenesis | 3.061595e-4 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 3.063845e-4 |
GO:0072236 | metanephric loop of Henle development | 3.099530e-4 |
GO:0044238 | primary metabolic process | 3.122245e-4 |
GO:0072091 | regulation of stem cell proliferation | 3.132766e-4 |
GO:0048339 | paraxial mesoderm development | 3.146563e-4 |
GO:0009890 | negative regulation of biosynthetic process | 3.190028e-4 |
GO:0061338 | atrioventricular node impulse conduction delay | 3.290589e-4 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 3.299038e-4 |
GO:0046546 | development of primary male sexual characteristics | 3.373015e-4 |
GO:0030879 | mammary gland development | 3.380856e-4 |
GO:0060285 | ciliary cell motility | 3.381922e-4 |
GO:0072194 | kidney smooth muscle tissue development | 3.381922e-4 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 3.381922e-4 |
GO:0060286 | flagellar cell motility | 3.411495e-4 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 3.411495e-4 |
GO:0042026 | protein refolding | 3.425099e-4 |
GO:0035108 | limb morphogenesis | 3.428238e-4 |
GO:0006463 | steroid hormone receptor complex assembly | 3.459938e-4 |
GO:0000075 | cell cycle checkpoint | 3.461672e-4 |
GO:0035117 | embryonic arm morphogenesis | 3.531006e-4 |
GO:0060039 | pericardium development | 3.550898e-4 |
GO:0007059 | chromosome segregation | 3.813137e-4 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 3.913680e-4 |
GO:0046544 | development of secondary male sexual characteristics | 3.964291e-4 |
GO:0045081 | negative regulation of interleukin-10 biosynthetic process | 3.964291e-4 |
GO:0051276 | chromosome organization | 3.973485e-4 |
GO:0043029 | T cell homeostasis | 3.978735e-4 |
GO:0002066 | columnar/cuboidal epithelial cell development | 4.021273e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 4.081170e-4 |
GO:0090398 | cellular senescence | 4.127112e-4 |
GO:0010894 | negative regulation of steroid biosynthetic process | 4.133404e-4 |
GO:0010159 | specification of organ position | 4.136531e-4 |
GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration | 4.314909e-4 |
GO:0072183 | negative regulation of nephron tubule epithelial cell differentiation | 4.314909e-4 |
GO:0060487 | lung epithelial cell differentiation | 4.476785e-4 |
GO:0031120 | snRNA pseudouridine synthesis | 4.486199e-4 |
GO:0060119 | inner ear receptor cell development | 4.490792e-4 |
GO:0048806 | genitalia development | 4.541221e-4 |
GO:0035425 | autocrine signaling | 4.619229e-4 |
GO:0042698 | ovulation cycle | 4.668701e-4 |
GO:0060021 | palate development | 4.707627e-4 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 4.755040e-4 |
GO:0040019 | positive regulation of embryonic development | 4.766975e-4 |
GO:0061325 | cell proliferation involved in outflow tract morphogenesis | 4.902185e-4 |
GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis | 4.902185e-4 |
GO:0032274 | gonadotropin secretion | 5.118502e-4 |
GO:0071824 | protein-DNA complex subunit organization | 5.146311e-4 |
GO:0071218 | cellular response to misfolded protein | 5.352383e-4 |
GO:0010501 | RNA secondary structure unwinding | 5.376771e-4 |
GO:0010564 | regulation of cell cycle process | 5.648631e-4 |
GO:0072070 | loop of Henle development | 5.691498e-4 |
GO:0001947 | heart looping | 5.702257e-4 |
GO:0033554 | cellular response to stress | 5.819707e-4 |
GO:0035966 | response to topologically incorrect protein | 5.831476e-4 |
GO:0003306 | Wnt receptor signaling pathway involved in heart development | 5.931107e-4 |
GO:0051890 | regulation of cardioblast differentiation | 5.979783e-4 |
GO:0060976 | coronary vasculature development | 6.010684e-4 |
GO:0003344 | pericardium morphogenesis | 6.097327e-4 |
GO:2000484 | positive regulation of interleukin-8 secretion | 6.097327e-4 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 6.169556e-4 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 6.169556e-4 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 6.169556e-4 |
GO:0002331 | pre-B cell allelic exclusion | 6.169556e-4 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 6.292400e-4 |
GO:2000064 | regulation of cortisol biosynthetic process | 6.611871e-4 |
GO:0042350 | GDP-L-fucose biosynthetic process | 6.611871e-4 |
GO:0006545 | glycine biosynthetic process | 6.611871e-4 |
GO:0090239 | regulation of histone H4 acetylation | 6.626299e-4 |
GO:0014057 | positive regulation of acetylcholine secretion | 6.626299e-4 |
GO:0060340 | positive regulation of type I interferon-mediated signaling pathway | 6.773722e-4 |
GO:0003206 | cardiac chamber morphogenesis | 6.889755e-4 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 7.034619e-4 |
GO:0021800 | cerebral cortex tangential migration | 7.034619e-4 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 7.076696e-4 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 7.270495e-4 |
GO:0048469 | cell maturation | 7.439429e-4 |
GO:0014029 | neural crest formation | 7.506733e-4 |
GO:0030819 | positive regulation of cAMP biosynthetic process | 7.604583e-4 |
GO:0001936 | regulation of endothelial cell proliferation | 7.981886e-4 |
GO:0061337 | cardiac conduction | 8.211174e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 8.294586e-4 |
GO:0009067 | aspartate family amino acid biosynthetic process | 8.836549e-4 |
GO:0008629 | induction of apoptosis by intracellular signals | 8.929176e-4 |
GO:0008354 | germ cell migration | 9.023365e-4 |
GO:0090037 | positive regulation of protein kinase C signaling cascade | 9.155274e-4 |
GO:0048539 | bone marrow development | 9.185338e-4 |
GO:0034720 | histone H3-K4 demethylation | 9.185338e-4 |
GO:2000369 | regulation of clathrin-mediated endocytosis | 9.321405e-4 |
GO:0031327 | negative regulation of cellular biosynthetic process | 9.371556e-4 |
GO:0003156 | regulation of organ formation | 9.575527e-4 |
GO:0046543 | development of secondary female sexual characteristics | 9.768464e-4 |
GO:0060430 | lung saccule development | 9.805614e-4 |
GO:0051881 | regulation of mitochondrial membrane potential | 9.805614e-4 |
GO:0003148 | outflow tract septum morphogenesis | 9.812870e-4 |
GO:0035404 | histone-serine phosphorylation | 1.007732e-3 |
GO:0007399 | nervous system development | 1.015339e-3 |
GO:0040008 | regulation of growth | 1.033803e-3 |
GO:0001539 | ciliary or flagellar motility | 1.096680e-3 |
GO:0032909 | regulation of transforming growth factor beta2 production | 1.100147e-3 |
GO:0030514 | negative regulation of BMP signaling pathway | 1.110748e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 1.123050e-3 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.144804e-3 |
GO:0021986 | habenula development | 1.150613e-3 |
GO:0072133 | metanephric mesenchyme morphogenesis | 1.150613e-3 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 1.224797e-3 |
GO:0010765 | positive regulation of sodium ion transport | 1.246877e-3 |
GO:2000615 | regulation of histone H3-K9 acetylation | 1.262117e-3 |
GO:0060574 | intestinal epithelial cell maturation | 1.262117e-3 |
GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 1.262117e-3 |
GO:0033566 | gamma-tubulin complex localization | 1.262117e-3 |
GO:0071843 | cellular component biogenesis at cellular level | 1.276743e-3 |
GO:0016180 | snRNA processing | 1.316812e-3 |
GO:0051096 | positive regulation of helicase activity | 1.317897e-3 |
GO:0016556 | mRNA modification | 1.317897e-3 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 1.327876e-3 |
GO:0021915 | neural tube development | 1.350575e-3 |
GO:2000242 | negative regulation of reproductive process | 1.354148e-3 |
GO:0060236 | regulation of mitotic spindle organization | 1.358390e-3 |
GO:0009235 | cobalamin metabolic process | 1.358390e-3 |
GO:0006529 | asparagine biosynthetic process | 1.358390e-3 |
GO:0055117 | regulation of cardiac muscle contraction | 1.389491e-3 |
GO:0030857 | negative regulation of epithelial cell differentiation | 1.439323e-3 |
GO:0007050 | cell cycle arrest | 1.442565e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 1.451267e-3 |
GO:0002262 | myeloid cell homeostasis | 1.464157e-3 |
GO:0051402 | neuron apoptosis | 1.513623e-3 |
GO:0060068 | vagina development | 1.531246e-3 |
GO:0045136 | development of secondary sexual characteristics | 1.538134e-3 |
GO:0021827 | postnatal olfactory bulb interneuron migration | 1.580168e-3 |
GO:0046654 | tetrahydrofolate biosynthetic process | 1.590979e-3 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 1.590979e-3 |
GO:0035584 | calcium-mediated signaling using intracellular calcium source | 1.590979e-3 |
GO:0048843 | negative regulation of axon extension involved in axon guidance | 1.596218e-3 |
GO:0042491 | auditory receptor cell differentiation | 1.605587e-3 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.610946e-3 |
GO:0001843 | neural tube closure | 1.625359e-3 |
GO:0009755 | hormone-mediated signaling pathway | 1.626222e-3 |
GO:0046620 | regulation of organ growth | 1.641385e-3 |
GO:0071681 | cellular response to indole-3-methanol | 1.647114e-3 |
GO:0043482 | cellular pigment accumulation | 1.647114e-3 |
GO:0045739 | positive regulation of DNA repair | 1.664965e-3 |
GO:0060788 | ectodermal placode formation | 1.667832e-3 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 1.671244e-3 |
GO:0071425 | hemopoietic stem cell proliferation | 1.694614e-3 |
GO:0060486 | Clara cell differentiation | 1.701808e-3 |
GO:0030823 | regulation of cGMP metabolic process | 1.701808e-3 |
GO:0003006 | developmental process involved in reproduction | 1.750920e-3 |
GO:0060986 | endocrine hormone secretion | 1.800270e-3 |
GO:0010870 | positive regulation of receptor biosynthetic process | 1.832616e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 1.832616e-3 |
GO:0003231 | cardiac ventricle development | 1.837103e-3 |
GO:0055021 | regulation of cardiac muscle tissue growth | 1.858468e-3 |
GO:0060686 | negative regulation of prostatic bud formation | 1.867789e-3 |
GO:0042471 | ear morphogenesis | 1.867824e-3 |
GO:0006998 | nuclear envelope organization | 1.887250e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.905753e-3 |
GO:0070979 | protein K11-linked ubiquitination | 1.930180e-3 |
GO:2000380 | regulation of mesoderm development | 2.003556e-3 |
GO:0048852 | diencephalon morphogenesis | 2.003556e-3 |
GO:0051964 | negative regulation of synapse assembly | 2.025640e-3 |
GO:0003254 | regulation of membrane depolarization | 2.063438e-3 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 2.121458e-3 |
GO:0060379 | cardiac muscle cell myoblast differentiation | 2.121458e-3 |
GO:0003127 | detection of nodal flow | 2.121458e-3 |
GO:0031129 | inductive cell-cell signaling | 2.121458e-3 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 2.121458e-3 |
GO:0030262 | apoptotic nuclear change | 2.130998e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 2.136514e-3 |
GO:0048389 | intermediate mesoderm development | 2.136514e-3 |
GO:0007412 | axon target recognition | 2.136514e-3 |
GO:0031018 | endocrine pancreas development | 2.158993e-3 |
GO:0060749 | mammary gland alveolus development | 2.178388e-3 |
GO:0060606 | tube closure | 2.255969e-3 |
GO:0046653 | tetrahydrofolate metabolic process | 2.285208e-3 |
GO:0003166 | bundle of His development | 2.285208e-3 |
GO:0035148 | tube formation | 2.285772e-3 |
GO:0034660 | ncRNA metabolic process | 2.300080e-3 |
GO:0051961 | negative regulation of nervous system development | 2.371330e-3 |
GO:0050665 | hydrogen peroxide biosynthetic process | 2.371330e-3 |
GO:0006085 | acetyl-CoA biosynthetic process | 2.371330e-3 |
GO:0051642 | centrosome localization | 2.389916e-3 |
GO:0042490 | mechanoreceptor differentiation | 2.396356e-3 |
GO:0034698 | response to gonadotropin stimulus | 2.422071e-3 |
GO:0006610 | ribosomal protein import into nucleus | 2.452380e-3 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 2.459293e-3 |
GO:0032439 | endosome localization | 2.461695e-3 |
GO:0031104 | dendrite regeneration | 2.461695e-3 |
GO:0060603 | mammary gland duct morphogenesis | 2.491132e-3 |
GO:0050922 | negative regulation of chemotaxis | 2.524404e-3 |
GO:0051052 | regulation of DNA metabolic process | 2.538600e-3 |
GO:0000209 | protein polyubiquitination | 2.583064e-3 |
GO:0030825 | positive regulation of cGMP metabolic process | 2.596421e-3 |
GO:0072203 | cell proliferation involved in metanephros development | 2.596421e-3 |
GO:0006916 | anti-apoptosis | 2.610228e-3 |
GO:0043401 | steroid hormone mediated signaling pathway | 2.621624e-3 |
GO:0031572 | G2/M transition DNA damage checkpoint | 2.631613e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 2.658930e-3 |
GO:0046755 | non-lytic virus budding | 2.658930e-3 |
GO:0000077 | DNA damage checkpoint | 2.703048e-3 |
GO:0048732 | gland development | 2.717465e-3 |
GO:0046449 | creatinine metabolic process | 2.729786e-3 |
GO:0043217 | myelin maintenance | 2.759584e-3 |
GO:0070286 | axonemal dynein complex assembly | 2.798895e-3 |
GO:0048598 | embryonic morphogenesis | 2.975967e-3 |
GO:0000413 | protein peptidyl-prolyl isomerization | 2.978551e-3 |
GO:0000710 | meiotic mismatch repair | 2.996302e-3 |
GO:0043276 | anoikis | 2.996302e-3 |
GO:0031128 | developmental induction | 3.090656e-3 |
GO:0006334 | nucleosome assembly | 3.141056e-3 |
GO:0034470 | ncRNA processing | 3.142927e-3 |
GO:0045599 | negative regulation of fat cell differentiation | 3.168217e-3 |
GO:0045766 | positive regulation of angiogenesis | 3.176904e-3 |
GO:0072166 | posterior mesonephric tubule development | 3.177465e-3 |
GO:0032347 | regulation of aldosterone biosynthetic process | 3.177465e-3 |
GO:0071044 | histone mRNA catabolic process | 3.193548e-3 |
GO:0050869 | negative regulation of B cell activation | 3.233030e-3 |
GO:0034508 | centromere complex assembly | 3.281084e-3 |
GO:0061326 | renal tubule development | 3.355298e-3 |
GO:0071480 | cellular response to gamma radiation | 3.428668e-3 |
GO:0031570 | DNA integrity checkpoint | 3.540049e-3 |
GO:0046590 | embryonic leg morphogenesis | 3.584821e-3 |
GO:0030278 | regulation of ossification | 3.605828e-3 |
GO:0001841 | neural tube formation | 3.712213e-3 |
GO:0003219 | cardiac right ventricle formation | 3.727504e-3 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 3.751863e-3 |
GO:0043487 | regulation of RNA stability | 3.757664e-3 |
GO:0006921 | cellular component disassembly involved in apoptosis | 3.842428e-3 |
GO:0009948 | anterior/posterior axis specification | 3.848828e-3 |
GO:0060113 | inner ear receptor cell differentiation | 3.865839e-3 |
GO:0008334 | histone mRNA metabolic process | 3.947515e-3 |
GO:0003061 | positive regulation of the force of heart contraction by norepinephrine | 3.967253e-3 |
GO:0060480 | lung goblet cell differentiation | 3.967253e-3 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 3.967253e-3 |
GO:0010157 | response to chlorate | 3.967253e-3 |
GO:2000351 | regulation of endothelial cell apoptosis | 3.994636e-3 |
GO:0090102 | cochlea development | 4.000464e-3 |
GO:0006986 | response to unfolded protein | 4.007557e-3 |
GO:0048378 | regulation of lateral mesodermal cell fate specification | 4.036262e-3 |
GO:0006269 | DNA replication, synthesis of RNA primer | 4.036262e-3 |
GO:0030862 | positive regulation of polarized epithelial cell differentiation | 4.046883e-3 |
GO:0022414 | reproductive process | 4.105979e-3 |
GO:0022029 | telencephalon cell migration | 4.186104e-3 |
GO:0042981 | regulation of apoptosis | 4.195371e-3 |
GO:0060420 | regulation of heart growth | 4.205443e-3 |
GO:0043067 | regulation of programmed cell death | 4.247183e-3 |